NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders
- 1 September 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Harvard Review of Psychiatry
- Vol. 7 (3) , 125-143
- https://doi.org/10.1093/hrp/7.3.125
Abstract
Antagonists of the N -methyl- D -aspartate (NMDA) subclass of glutamate receptors and agonist of the glycine-B coagnoist site of these receptors have been important tools for characterizing the con...This publication has 17 references indexed in Scilit:
- Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptorsPharmacology Biochemistry and Behavior, 1989
- Regional distribution of [3H]MK-801 binding sites in the human brainBrain Research, 1989
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989
- Differential loss of striatal projection neurons in Huntington disease.Proceedings of the National Academy of Sciences, 1988
- Impairments on Neuropsychologic Tests of Temporohippocampal and Frontohippocampal Functions and Word Fluency in Remitting Schizophrenia and Affective DisordersArchives of General Psychiatry, 1988
- Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependenceArchives of internal medicine (1960), 1987
- Involvement of N‐methyl‐D‐aspartate receptors in epileptiform bursting in the rat hippocampal slice.The Journal of Physiology, 1986
- A polymorphic DNA marker genetically linked to Huntington's diseaseNature, 1983
- The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartateBritish Journal of Pharmacology, 1983
- Specific [3H]phencyclidine binding in rat central nervous system.Proceedings of the National Academy of Sciences, 1979